Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer. Issue 12 (2nd September 2020)
- Record Type:
- Journal Article
- Title:
- Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer. Issue 12 (2nd September 2020)
- Main Title:
- Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer
- Authors:
- Tavukcuoglu, Ece
Horzum, Utku
Yanik, Hamdullah
Uner, Aysegul
Yoyen‐Ermis, Digdem
Nural, Safa K.
Aydin, Busra
Sokmensuer, Cenk
Karakoc, Derya
Yilmaz, Kerim Bora
Hamaloglu, Erhan
Esendagli, Gunes - Abstract:
- Abstract: In contrast to the mouse, functional assets of polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) in the human spleen remain to be better elucidated. Here, we report that the spleen in gastric and pancreatic cancer adopts an immune regulatory character, harbors excessive amount of PMN‐MDSC, and anatomically enables their interaction with T cells. Compared to the peripheral blood, the spleen from cancer patients contained significantly higher levels of low‐density PMN‐MDSC, but not early‐stage MDSC (e‐MDSC) and monocytic‐MDSC (M‐MDSC). Low‐density fraction of polymorphonuclear (PMN) cells was enriched in immature myeloid cells and displayed higher levels of CD10, CD16, and ROS than their blood‐derived counterparts. They were also positive for PD‐L1, LOX‐1, and pSTAT3. The white pulp and periarteriolar lymphoid sheath (PALS) were strategically surrounded by PMN cells that were in contact with T cells. Unlike those from the blood, both low‐density and normal‐density PMN cells from the human spleen suppressed T cell proliferation and IFN‐γ production. Independent of clinical grade, high PMN‐MDSC percentages were associated with decreased survival in gastric cancer. In summary, our results outline the immune regulatory role of the spleen in cancer where neutrophils acquire MDSC functions and feasibly interact with T cells. Abstract : In cancer, the human spleen serves as a reservoir for myeloid‐derived suppressor cells (MDSC), especially PMN‐MDSC. ComparativeAbstract: In contrast to the mouse, functional assets of polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) in the human spleen remain to be better elucidated. Here, we report that the spleen in gastric and pancreatic cancer adopts an immune regulatory character, harbors excessive amount of PMN‐MDSC, and anatomically enables their interaction with T cells. Compared to the peripheral blood, the spleen from cancer patients contained significantly higher levels of low‐density PMN‐MDSC, but not early‐stage MDSC (e‐MDSC) and monocytic‐MDSC (M‐MDSC). Low‐density fraction of polymorphonuclear (PMN) cells was enriched in immature myeloid cells and displayed higher levels of CD10, CD16, and ROS than their blood‐derived counterparts. They were also positive for PD‐L1, LOX‐1, and pSTAT3. The white pulp and periarteriolar lymphoid sheath (PALS) were strategically surrounded by PMN cells that were in contact with T cells. Unlike those from the blood, both low‐density and normal‐density PMN cells from the human spleen suppressed T cell proliferation and IFN‐γ production. Independent of clinical grade, high PMN‐MDSC percentages were associated with decreased survival in gastric cancer. In summary, our results outline the immune regulatory role of the spleen in cancer where neutrophils acquire MDSC functions and feasibly interact with T cells. Abstract : In cancer, the human spleen serves as a reservoir for myeloid‐derived suppressor cells (MDSC), especially PMN‐MDSC. Comparative analyses revealed functional and phenotypic similarities and distinctions between the splenic PMN‐MDSC and the circulating PMN‐MDSC. The spleen has a critical immune regulatory role in cancer patients. … (more)
- Is Part Of:
- European journal of immunology. Volume 50:Issue 12(2020)
- Journal:
- European journal of immunology
- Issue:
- Volume 50:Issue 12(2020)
- Issue Display:
- Volume 50, Issue 12 (2020)
- Year:
- 2020
- Volume:
- 50
- Issue:
- 12
- Issue Sort Value:
- 2020-0050-0012-0000
- Page Start:
- 2067
- Page End:
- 2074
- Publication Date:
- 2020-09-02
- Subjects:
- neutrophil -- granulocyte -- granulocytic MDSC -- spleen -- cancer
Immunology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/eji.202048666 ↗
- Languages:
- English
- ISSNs:
- 0014-2980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.730100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24573.xml